Vimarsana
Biggest News Aggregation in the World

Bruce Culleton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bruce Culleton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bruce Culleton Today - Breaking & Trending Today

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering - Vimarsana News

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

WINSTON-SALEM, N.C., June 11, 2024 -- ProKidney Corp. , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease, today announced the pricing of an...

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations - Vimarsana News

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

Dr. Ulrich Ernst joins as Executive Vice President of Technical Operations with a deep background and expertise in process development and manufac...

Manufacturing highs, lows dominate top-10 business stories - Vimarsana News

Manufacturing highs, lows dominate top-10 business stories

There were waves of promising economic-development projects announced in the Triad in 2023 with thousands of production jobs and billions of capital investments pledged by new or expanding businesses.

ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer - ProKidney (NASDAQ:PROK) - Vimarsana News

ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer - ProKidney (NASDAQ:PROK)

WINSTON-SALEM, N.C., Nov. 30, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (NASDAQ:PROK) ("ProKidney"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced

ProKidney Corp. (NASDAQ:PROK) Q3 2023 Earnings Call Transcript - Vimarsana News

ProKidney Corp. (NASDAQ:PROK) Q3 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the ProKidney Corporate Update Conference Call. At this time, all lines are in a listen-only mode.